{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:21:37Z","timestamp":1773300097116,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["LCTT"],"DOI":"10.2147\/lctt.s138887","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T22:19:01Z","timestamp":1501798741000},"page":"91-99","source":"Crossref","is-referenced-by-count":6,"title":["New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer"],"prefix":"10.2147","volume":"Volume 8","author":[{"given":"Maiko","family":"Niki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shosaku","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,8]]},"container-title":["Lung Cancer: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=37780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=37780","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T22:19:02Z","timestamp":1501798742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/new-prognostic-biomarkers-and-therapeutic-effect-of-bevacizumab-for-pa-peer-reviewed-article-LCTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/lctt.s138887","relation":{},"ISSN":["1179-2728"],"issn-type":[{"value":"1179-2728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}